218 related articles for article (PubMed ID: 17581351)
1. Sarcoid-like reaction in the spleen following chemotherapy for non-Hodgkin's lymphoma.
Reilly TB; Schuster DM; Starsiak MD; Kost CB; Halkar RK
Clin Nucl Med; 2007 Jul; 32(7):569-71. PubMed ID: 17581351
[No Abstract] [Full Text] [Related]
2. Cyclophosphamide, pegylated liposomal doxorubicin, vincristine and prednisone (CDOP) plus rituximab is effective and well tolerated in poor performance status elderly patients with non-Hodgkin's lymphoma.
Visani G; Guiducci B; D'Adamo F; Mele A; Nicolini G; Leopardi G; Sparaventi G; Barulli S; Malerba L; Isidori A; Malagola M; Piccaluga PP
Leuk Lymphoma; 2005 Mar; 46(3):477-9. PubMed ID: 15621843
[No Abstract] [Full Text] [Related]
3. Drug-induced pneumonitis detected earlier by 18F-FDG-PET than by high-resolution CT: a case report with non-Hodgkin's lymphoma.
Yamane T; Daimaru O; Ito S; Nagata T; Yoshiya K; Fukaya N; Ito S; Imai T; Uchida H
Ann Nucl Med; 2008 Oct; 22(8):719-22. PubMed ID: 18982476
[TBL] [Abstract][Full Text] [Related]
4. Fatal interstitial pneumonitis related to rituximab-containing regimen.
Herishanu Y; Polliack A; Leider-Trejo L; Grieff Y; Metser U; Naparstek E
Clin Lymphoma Myeloma; 2006 Mar; 6(5):407-9. PubMed ID: 16640819
[TBL] [Abstract][Full Text] [Related]
5. Combined therapy with rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP) for Sjögren's syndrome-associated B-cell aggressive non-Hodgkin's lymphomas.
Voulgarelis M; Giannouli S; Anagnostou D; Tzioufas AG
Rheumatology (Oxford); 2004 Aug; 43(8):1050-3. PubMed ID: 15187246
[TBL] [Abstract][Full Text] [Related]
6. Primary non-Hodgkin lymphoma of cervix successfully treated with rituximab: positron emission tomography images before and after therapy: a case report.
Ustaalioglu BB; Bilici A; Seker M; Canpolat N; Ozdemir N; Salepci T; Gumus M
Leuk Res; 2010 Apr; 34(4):e108-10. PubMed ID: 19931906
[No Abstract] [Full Text] [Related]
7. Early response assessment using 3'-deoxy-3'-[18F]fluorothymidine-positron emission tomography in high-grade non-Hodgkin's lymphoma.
Herrmann K; Wieder HA; Buck AK; Schöffel M; Krause BJ; Fend F; Schuster T; Meyer zum Büschenfelde C; Wester HJ; Duyster J; Peschel C; Schwaiger M; Dechow T
Clin Cancer Res; 2007 Jun; 13(12):3552-8. PubMed ID: 17575218
[TBL] [Abstract][Full Text] [Related]
8. False-positive FDG-PET findings due to bone metastasis from prostate cancer in staging of non-Hodgkin's lymphoma.
Inoue Y; Tamaki H; Yamagami T; Iwasaki H; Nakatsuka S; Soma T
Eur J Haematol; 2007 Jul; 79(1):88-90. PubMed ID: 17532762
[No Abstract] [Full Text] [Related]
9. Rituximab plus CHOP as an initial chemotherapy for patients with disseminated MALT lymphoma.
Ennishi D; Yokoyama M; Mishima Y; Watanabe C; Terui Y; Takahashi S; Takeuchi K; Ikeda K; Tanimoto M; Hatake K
Leuk Lymphoma; 2007 Nov; 48(11):2241-3. PubMed ID: 17990181
[No Abstract] [Full Text] [Related]
10. Primary endometrial non-Hodgkin's lymphoma treated by chemotherapy and radiotherapy.
Guldrís EM; Vázquez P; Fernández A
Acta Obstet Gynecol Scand; 2013 May; 92(5):606. PubMed ID: 23398244
[No Abstract] [Full Text] [Related]
11. Occurrence of sarcoidosis after chemotherapy for non-Hodgkin lymphoma.
Cho H; Yoon DH; Kim JH; Ko YB; Kwon BS; Song IH; Suh C
Korean J Intern Med; 2016 May; 31(3):605-7. PubMed ID: 26968186
[No Abstract] [Full Text] [Related]
12. Neutropenic enterocolitis.
Singhal M; Lal A; Vyas S; Gulati A
Indian J Cancer; 2007; 44(3):122-3. PubMed ID: 18250536
[TBL] [Abstract][Full Text] [Related]
13. Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era.
Avivi I; Zilberlicht A; Dann EJ; Leiba R; Faibish T; Rowe JM; Bar-Shalom R
Am J Hematol; 2013 May; 88(5):400-5. PubMed ID: 23423884
[TBL] [Abstract][Full Text] [Related]
14. Phase 3 study of frontline rituximab, cyclophosphamide, doxorubicin, and prednisone plus vincristine (R-CHOP) or bortezomib (VR-CAP) in transplantation-unsuitable mantle cell lymphoma (MCL) patients.
Clin Adv Hematol Oncol; 2014 Aug; 12(8 Suppl 16):9-11. PubMed ID: 25768994
[No Abstract] [Full Text] [Related]
15. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Coiffier B; Lepage E; Briere J; Herbrecht R; Tilly H; Bouabdallah R; Morel P; Van Den Neste E; Salles G; Gaulard P; Reyes F; Lederlin P; Gisselbrecht C
N Engl J Med; 2002 Jan; 346(4):235-42. PubMed ID: 11807147
[TBL] [Abstract][Full Text] [Related]
16. A Bayesian approach to a patient with a residual mass after treatment for non-Hodgkin's lymphoma of the thyroid.
Bibb J; Hromas R; Rabinowitz I
J Clin Oncol; 2005 Dec; 23(34):8911-3. PubMed ID: 16314654
[No Abstract] [Full Text] [Related]
17. Failure of fluorodeoxyglucose positron emission tomography to detect the high-grade transformation of nodular lymphocyte predominant Hodgkin's lymphoma.
Puyade M; Yacoub M; Tomowiak C; Diviné M; Perdrisot R; Guilhot F; Delwail V
Acta Haematol; 2013; 129(4):229-31. PubMed ID: 23328622
[No Abstract] [Full Text] [Related]
18. Rituximab-CHOP induced interstitial pneumonitis in patients with disseminated extranodal marginal zone B cell lymphoma.
Kim KM; Kim HC; Jeon KN; Kim HG; Kang JH; Hahm JR; Lee GW
Yonsei Med J; 2008 Feb; 49(1):155-8. PubMed ID: 18306483
[TBL] [Abstract][Full Text] [Related]
19. Adapted CHOP plus rituximab in non-Hodgkin's lymphoma in patients over 80 years old.
Italiano A; Jardin F; Peyrade F; Saudes L; Tilly H; Thyss A
Haematologica; 2005 Sep; 90(9):1281-3. PubMed ID: 16154857
[TBL] [Abstract][Full Text] [Related]
20. Essential thrombocythemia after treatment of non-Hodgkin's lymphoma.
Maciel JF; de Lourdes Chauffaille M; Inaoka RJ; Colleoni GW; Yamamoto M
Leuk Res; 2007 Nov; 31(11):1593-5. PubMed ID: 17324461
[No Abstract] [Full Text] [Related]
[Next] [New Search]
